Monday, January 30, 2017

BRIEF-Teva Pharmaceutical confirms court decision in Copaxone 40 mg/ml patent trial

* Teva confirms district court decision in Copaxone 40

mg/ml patent trial

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)